Rapid Micro Biosystems (NASDAQ:RPID) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Rapid Micro Biosystems (NASDAQ:RPID) from a sell rating to a hold rating in a research report released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Rapid Micro Biosystems currently has a consensus rating of “Hold” and an average target price of $8.00.

Rapid Micro Biosystems Trading Up 2.6%

NASDAQ:RPID opened at $3.91 on Friday. The company has a market cap of $173.29 million, a PE ratio of -3.87 and a beta of 1.38. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42. The company has a 50 day simple moving average of $3.66 and a two-hundred day simple moving average of $3.40. Rapid Micro Biosystems has a 12 month low of $1.86 and a 12 month high of $4.94.

Insiders Place Their Bets

In related news, major shareholder Longitude Capital Partners Ii, sold 49,000 shares of Rapid Micro Biosystems stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $3.88, for a total transaction of $190,120.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Robert G. Jr. Spignesi sold 12,840 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $3.78, for a total value of $48,535.20. Following the sale, the chief executive officer directly owned 962,097 shares of the company’s stock, valued at $3,636,726.66. This represents a 1.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 153,716 shares of company stock worth $635,998. 29.96% of the stock is owned by insiders.

Institutional Investors Weigh In On Rapid Micro Biosystems

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Susquehanna International Group LLP lifted its stake in shares of Rapid Micro Biosystems by 12.6% during the 3rd quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock valued at $195,000 after buying an additional 6,528 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Rapid Micro Biosystems by 37.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after buying an additional 15,255 shares in the last quarter. Vanguard Group Inc. raised its holdings in Rapid Micro Biosystems by 6.7% during the third quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after acquiring an additional 60,655 shares during the period. Geode Capital Management LLC lifted its position in shares of Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock valued at $704,000 after acquiring an additional 3,143 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp purchased a new position in shares of Rapid Micro Biosystems in the fourth quarter valued at about $71,000. 52.60% of the stock is owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.